title: [Dysfunction of the Oddi's sphincter].
authors.affiliation: Service d'hépato. Gastroentérologie, Hôpital de La Timone, 264 rue Saint Pierre, 13385 Marseille. rlaugier@mail.ap-hm.fr
authors.forename: R
authors.initials: R
authors.lastname: Laugier
authors.forename: P
authors.initials: P
authors.lastname: Grandval
authors.forename: E
authors.initials: E
authors.lastname: Ville
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use; D002763:Cholecystectomy; D003137:Common Bile Duct Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery; D018849:Controlled Clinical Trials as Topic; D003937:Diagnosis, Differential; D004724:Endoscopy; D005260:Female; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006923:Hymecromone / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008365:Manometry; D008875:Middle Aged; D009543:Nifedipine / Q000008:administration & dosage / Q000627:therapeutic use; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use; D012307:Risk Factors; D009803:Sphincter of Oddi / Q000502:physiology; D016717:Sphincterotomy, Endoscopic; D013997:Time Factors; D014287:Trimebutine / Q000008:administration & dosage / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D002121:Calcium Channel Blockers; D005765:Gastrointestinal Agents; D010276:Parasympatholytics; D014665:Vasodilator Agents; D006923:Hymecromone; D009543:Nifedipine; D014287:Trimebutine
vernacular_title: Dysfonction du sphincter d'Oddi.